Med Biogene Inc. appoints Erinn B. Broshko as its new Chief Executive Officer and a director
Med BioGene Inc. (MBI) announced the appointment of Erinn B. Broshko as Chief Executive Officer and a director of MBI.
Prior to joining MBI, Mr. Broshko was a corporate and securities lawyer with the Vancouver law firm of Farris, Vaughan, Wills & Murphy LLP. Mr. Broshko's legal practice was focussed primarily on biotechnology companies. Mr. Broshko holds a B.A. (hons) and M.A. from the University of Saskatchewan, an LL.B. from Dalhousie Law School and an M.B.A. from the University of British Columbia.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.